SMN1 gene duplications are more frequent in patients with progressive muscular atrophy

References

• Lefebvre S, Burglen L, Roboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155–65.
   PubMed Web of Science ®Google Scholar
• Corcia P, Mayeux-Portas V, Khoris J, de Toffol B, Autret A, Müh JP, et al. Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis. Ann Neurol. 2002;51:243–6.
   PubMed Web of Science ®Google Scholar
• Corcia P, Camu W , Halimi J-M, Vourc’h P, Antar C, Vedrine S, et al. SMN1 gene, but not SMN2, is a risk factor for sporadic ALS. Neurology. 2006;67;1147–50
   PubMed Web of Science ®Google Scholar
• Turner BJ, Parkinson NJ, Davies KE, Talbot K. Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model. Neurobiology of Disease. 2009;34:511–7.
   PubMed Web of Science ®Google Scholar
• Corcia P, Camu W, Praline J, Gordon PH, Vourch P, Andres C. The importance of the SMN genes in the genetics of sporadic ALS. Amyotroph Lateral Scler. 2009;10:436–40.
   PubMed Web of Science ®Google Scholar
• Blauw HM, Barnes CP, van Vught PWJ, van Rheenen, Verheul M, Cuppen E, et al. SMN1 gene duplications are associated with sporadic ALS. Neurology. 2012;78:776–80.
   PubMed Web of Science ®Google Scholar
• Brooks BB, Miller RG, Swash M, Munsat T. El Escorial revisited: revisited criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Floyd AG, Yu QP, Piboolnurak P, Tang MX, Fang Y, Smith WA, et al. Transcranial magnetic stimulation in ALS: utility of central motor conduction tests. Neurology. 2009;72: 498–504.
   PubMed Web of Science ®Google Scholar
• van der Graaff MM, Lavini C, Akkerman EM, Majoie ChB, Nederveen AJ, Zwinderman AH, et al. MR spectroscopy findings in early stages of motor neuron disease. Am J Neuroradiol. 2010;31:1799–806.
   PubMed Web of Science ®Google Scholar
• Lawyer T, Netsky MG. Amyotrophic lateral sclerosis: a clinicopathological study of 50 cases. Arch Neurol Psychiat. 1953;69:171–92.
   PubMedGoogle Scholar
• Ince PG, Evans J, Knopp M, Forster G, Hamdalla HH, Wharton SB, et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology. 2003;60:1252–8.
   PubMed Web of Science ®Google Scholar
• Kim WK, Liu X, Sandner J, Pasmantier M, Andrews J, Rowland LP, et al. Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology. 2009; 73:1686–92.
   PubMed Web of Science ®Google Scholar
• Moulard B, Salachas F, Chassande B, Briolotti V, Meininger V, Malafosse A, et al. Association between centromeric deletions of the SMN gene and sporadic adult-onset lower motor neuron disease. Ann Neurol. 1998;43:640–4.
   PubMed Web of Science ®Google Scholar
• Kim J, Lee S-G, Choi Y-C, Kang S-W, Lee J-B, Choi J-R, et al. Association between survivor motor neuron 2 (SMN2) gene homozygous deletion and sporadic lower motor neuron disease in a Korean population. Ann Clin Lab Sci. 2010;40: 368–74.
   PubMed Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nuclei Acids Res. 1988;16:1215.
   PubMed Web of Science ®Google Scholar
• Jędrzejowska M, Borkowska J, Zimowski J, Kostera-Pruszczyk A, Milewski M, Jurek M, et al. Unaffected patients with a homozygous absence of the SMN1 gene. Europ J Hum Genet. 2008;16:930–4.
   PubMed Web of Science ®Google Scholar
• Jędrzejowska M, Milewski M, Zimowiski J, Zagozdzon P, Kostera-Pruszczyk A, Borkowska J, et al. Incidence of spinal muscular atrophy in Poland – more frequent than predicted?Neuroepidemiology. 2010;34:152–7.
   PubMed Web of Science ®Google Scholar
• Kuźma M, Jamrozik Z, Barańczyk-Kuźma A. Activity and expression of glutatione S-transferase pi in patients with amyotrophic lateral sclerosis. Clin Chim Acta. 2006;364:217–21.
   PubMed Web of Science ®Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–5.
   PubMed Web of Science ®Google Scholar
• Usarek E, Gajewska B, Kaźmierczak B, Kuźma M, Dziewulska D, Barańczyk-Kuźma A. A study of glutatione S-transferase pi expression in central nervous system of subjects with amyotrophic lateral sclerosis using RNA extraction from formalin-fixed, paraffin-embedded material. Neurochem Res. 2005;30:1003–7.
   PubMed Web of Science ®Google Scholar
• van den Berg-Vos RM, Visser J, Franssen H, de Visser M, de Jong JM, Kalmijn S, et al. Sporadic lower motor neuron disease with adult onset: classification of subtypes. Brain. 2003;126:1036–47.
   PubMed Web of Science ®Google Scholar
• Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, et al. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012;135:847–52.
   PubMed Web of Science ®Google Scholar
• Norris FH. Adult progressive muscular atrophy and hereditary spinal muscular atrophies. In: Vinken PJ, Bruyn GW, Klawans HL, de Jong JMBV, editors. Handbook of Clinical Neurology: Diseases of the Motor System. Amsterdam: North-Holland Publishing Company; 1991. pp 13–34.
   Google Scholar
• de Carvalho M, Scotto M, Swash M. Clinical patterns in progressive muscular atrophy (PMA): a prospective study. Amyotroph Lateral Scler. 2007;8:296–9.
   PubMed Web of Science ®Google Scholar
• Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol. 2006; 253:1428–36.
   PubMed Web of Science ®Google Scholar
• Parboosingh JS, Meininger V, McKenna-Yasek D, Brown RH Jr, Rouleau GA. Deletions causing spinal muscular atrophy do not predispose to amyotrophic lateral sclerosis. Arch Neurol. 1999;56:710–2.
   PubMedGoogle Scholar
• Gamez J, Barcelo MJ, Munoz X, Carmona F, Cuscó I, Baiget M, et al. Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients. Neurology. 2002;59:1456–60.
   PubMed Web of Science ®Google Scholar
• Veldink JH, Kalmijn S, van der Hout AH, Lemmink HH, Groeneveld GJ, Lummen C, et al. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Neurology. 2005;65:820–5.
   PubMed Web of Science ®Google Scholar
• Hauke J, Riessland M, Lunke S, Eyüpoglu IY, Blümcke I, El-Osta A, et al. Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. Hum Mol Genet. 2009;18:304–17.
   PubMed Web of Science ®Google Scholar
• Coovert DD, Le TT, McAndrew PE, Strasswimmer J, Crawford TO, Mendell JR, et al. The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet. 1997;6:1205–14.
   PubMed Web of Science ®Google Scholar
• Milewski M, Jędrzejowska M, Jurek M, Sielska D, Borkowska J, Hausmanowa-Petrusewicz I. The relationship between the SMN protein expression level in fibroblasts and the clinical phenotype of SMA patients. EHGS Conference Praha 2005;P0854.
   Google Scholar
• Gu W, Lupski JR. CNV and nervous system diseases: what's new?Cytogenet Genome Res. 2008;123:54–64.
   PubMed Web of Science ®Google Scholar
• Shi J, Zhang T, Zhou Ch, Chohan MO, Gu X, Wegiel J, et al. Increased dosage of Dyrk1A alters alternative splicing factor (ASF). Regulated alternative splicing of Tau in Down syndrome. J Biol Chem. 2008;283:28660–9.
   Google Scholar
• Chari A, Pakina E, Fischer U. The role of RNP biogenesis in spinal muscular atrophy. Curr Opin Cell Biol. 2009;21: 387–93.
   PubMed Web of Science ®Google Scholar
• Lorson ChL, Rindt H, Shababi M. Spinal muscular atrophy: mechanism and therapeutic strategies. Hum Mol Genet. 2010;19:111–8.
   PubMed Web of Science ®Google Scholar